Peripheral neuropathy associated with tofacitinib use in alopecia universalis
Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss. Alopecia universalis (AU) is the advanced form of AA characterized by complete scalp and body hair loss. Traditional medical therapies for AA include topical and intralesional corticosteroids, topical anthralin imm...
Saved in:
Main Authors: | Raghad Alharthi (Author), Fatimah Alowirdi (Author), Saba Alsuhaymi (Author), Mohammed AlQahtani (Author), Afaf Alsheikh (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
by: Florian Anzengruber, et al.
Published: (2016) -
Improvement of atopic dermatitis and alopecia universalis with dupilumab: a case report
by: Lama Alotaibi, et al.
Published: (2021) -
Acne exacerbation after tofacitinib treatment for alopecia areata
by: Sawsan Alharthi, et al.
Published: (2021) -
Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
by: Tanja Todberg, et al.
Published: (2020) -
Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
by: Sophia A. Ederaine, BA, et al.
Published: (2022)